Stay updated with breaking news from Eric Schoen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Cognition Maintenance Study is a 6-month, Randomized Controlled Trial of Simufilam in Over 125 Patients with Alzheimer’s Disease.Primary Outcome Measures Are Safety and Change in Cognition... | May 11, 2023
New in vitro data from Europe show that simufilam can reverse altered filamin A protein in pituitary tumor cells, leading to improved cell signaling.Data suggest FLNA is a central factor influencing... | May 8, 2023
01.05.2023 - Over 1,244 Alzheimer’s patients now enrolled in Phase 3 studies of simufilam.Completion of patient enrollment for Phase 3 program still expected Q4 2023.$187.5 Million Cash and Cash Equivalents at March 31, 2023. AUSTIN, Texas, May 01, 2023 ...
953 Alzheimer’s Patients Are Now Enrolled Across Phase 3 Studies Both Phase 3 Studies Have Passed the Halfway Mark for Enrollment Goal Is to Complete...
Outside Biostatisticians with Specific Expertise in Alzheimer’s Disease Will Conduct an Independent Statistical Analysis on The Clinical Dataset. Clinical...